Several advanced methodologies have been developed to detect low-abundance molecules. These include digital PCR (dPCR), which provides high sensitivity and specificity, single-cell RNA sequencing (scRNA-seq) for analyzing RNA at the single-cell level, and enhanced mass spectrometry techniques for protein detection. These technologies enable researchers to gain insights into the molecular landscape of cancer at unprecedented resolution.
